D.E. Shaw & Co’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$35.3M Sell
108,276
-181,586
-63% -$59.2M 0.03% 495
2025
Q1
$78.3M Sell
289,862
-73,223
-20% -$19.8M 0.07% 241
2024
Q4
$85.4M Buy
363,085
+30,780
+9% +$7.24M 0.06% 237
2024
Q3
$91.4M Buy
332,305
+52,907
+19% +$14.6M 0.08% 190
2024
Q2
$67.9M Buy
279,398
+176,011
+170% +$42.8M 0.06% 232
2024
Q1
$15.5M Buy
103,387
+7,843
+8% +$1.17M 0.01% 716
2023
Q4
$18.3M Sell
95,544
-108,548
-53% -$20.8M 0.02% 613
2023
Q3
$36.1M Sell
204,092
-44,180
-18% -$7.82M 0.04% 340
2023
Q2
$47.2M Buy
248,272
+16,927
+7% +$3.22M 0.05% 279
2023
Q1
$46.3M Buy
231,345
+54,929
+31% +$11M 0.05% 281
2022
Q4
$41.9M Buy
176,416
+25,272
+17% +$6.01M 0.05% 316
2022
Q3
$30.3M Buy
151,144
+15,221
+11% +$3.05M 0.04% 405
2022
Q2
$19.8M Buy
135,923
+121,040
+813% +$17.7M 0.02% 614
2022
Q1
$2.43M Sell
14,883
-31,457
-68% -$5.14M ﹤0.01% 2298
2021
Q4
$7.86M Buy
46,340
+13,277
+40% +$2.25M 0.01% 1317
2021
Q3
$6.24M Sell
33,063
-3,345
-9% -$632K 0.01% 1316
2021
Q2
$6.17M Sell
36,408
-41,495
-53% -$7.03M 0.01% 1325
2021
Q1
$11M Buy
77,903
+13,402
+21% +$1.89M 0.01% 957
2020
Q4
$8.38M Sell
64,501
-105,737
-62% -$13.7M 0.01% 1046
2020
Q3
$24.8M Buy
170,238
+56,351
+49% +$8.2M 0.03% 532
2020
Q2
$16.9M Sell
113,887
-116,666
-51% -$17.3M 0.02% 644
2020
Q1
$25.1M Buy
230,553
+211,925
+1,138% +$23.1M 0.04% 403
2019
Q4
$2.15M Sell
18,628
-8,169
-30% -$941K ﹤0.01% 1572
2019
Q3
$2.16M Buy
26,797
+13,040
+95% +$1.05M ﹤0.01% 1525
2019
Q2
$998K Buy
13,757
+2,543
+23% +$184K ﹤0.01% 1885
2019
Q1
$1.05M Sell
11,214
-25,604
-70% -$2.39M ﹤0.01% 1833
2018
Q4
$2.68M Buy
36,818
+28,080
+321% +$2.05M ﹤0.01% 1382
2018
Q3
$765K Sell
8,738
-74,873
-90% -$6.56M ﹤0.01% 1916
2018
Q2
$8.24M Sell
83,611
-187,450
-69% -$18.5M 0.01% 905
2018
Q1
$32.3M Sell
271,061
-1,659
-0.6% -$198K 0.04% 383
2017
Q4
$34.6M Sell
272,720
-709,734
-72% -$90.2M 0.05% 343
2017
Q3
$115M Buy
982,454
+248,804
+34% +$29.2M 0.18% 107
2017
Q2
$58.5M Buy
733,650
+238,256
+48% +$19M 0.1% 214
2017
Q1
$25.4M Buy
495,394
+279,968
+130% +$14.3M 0.04% 386
2016
Q4
$8.07M Buy
215,426
+190,304
+758% +$7.12M 0.01% 783
2016
Q3
$1.7M Sell
25,122
-14,630
-37% -$992K ﹤0.01% 1462
2016
Q2
$2.21M Sell
39,752
-155,292
-80% -$8.62M ﹤0.01% 1391
2016
Q1
$12.2M Buy
195,044
+113,932
+140% +$7.15M 0.02% 587
2015
Q4
$7.64M Buy
81,112
+43,599
+116% +$4.1M 0.01% 761
2015
Q3
$3.02M Sell
37,513
-166,514
-82% -$13.4M ﹤0.01% 1174
2015
Q2
$24.5M Sell
204,027
-63,585
-24% -$7.62M 0.04% 421
2015
Q1
$27.9M Buy
267,612
+76,353
+40% +$7.97M 0.04% 371
2014
Q4
$18.6M Buy
191,259
+177,116
+1,252% +$17.2M 0.02% 461
2014
Q3
$1.11M Buy
14,143
+7,722
+120% +$603K ﹤0.01% 1511
2014
Q2
$406K Sell
6,421
-68,712
-91% -$4.34M ﹤0.01% 1963
2014
Q1
$5.04M Buy
75,133
+68,233
+989% +$4.58M 0.01% 874
2013
Q4
$444K Buy
6,900
+3,601
+109% +$232K ﹤0.01% 1987
2013
Q3
$211K Sell
3,299
-215,789
-98% -$13.8M ﹤0.01% 2197
2013
Q2
$6.79M Buy
+219,088
New +$6.79M 0.01% 690